Central Valley Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
Central Valley Advisors's LLY Position: Q2 2026 in Review
Central Valley Advisors reduced its Eli Lilly (LLY) stake by 0.32% in Q2 2026, selling an estimated $1.02K and leaving 310 shares worth $372K. The position accounts for 0.1% of the portfolio, ranked #139.
Central Valley Advisors first reported a position in LLY in Q1 2024 and has held it in 4 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Central Valley Advisors held 310 shares of Eli Lilly worth $372K as of Q2 2026.
- Central Valley Advisors sold 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
- Eli Lilly made up 0.1% of Central Valley Advisors's portfolio in Q2 2026, its #139 holding.
- Central Valley Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 4 quarters since.
- 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Central Valley Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.